Why choose Dulcoflex®
For constipation
Provides overnight relief
Is non-habit forming
Helps improve bowel movement
What’s inside
Bisacodyl I.P. 5mg
Dulcoflex® tablets and suppositories contain a single active ingredient, Bisacodyl I.P. 5mg, which plays a vital role in delivering effective constipation relief. By stimulating bowel muscles and softening stools, it facilitates easier passage and delivers effective relief.
How does it work
Dulcoflex® is a stimulant laxative that helps manage constipation. Its active ingredient—Biacasodyl stimulates bowel muscles, helping you pass stools and providing relief from constipation.
Directions for use
Dulcoflex® 5mg Suppository for Children
Medical advisory: Suppositories should only be used in your back passage.
1. Take off the foll wrapping
2. Lie on one side and pull your knees up towards your chest. Keep one leg drawn up more than the other
3. Use your first finger (index finger) or middle finger to push in the suppository
4. Gently push the suppository as far as possible into your back passage, pointed end first
5. Once it is as far as it will go, push it side-ways to make sure it touches the wall of the bowel
6. Lower your legs to a comfortable position whilst the suppository is retained in place
7. Keep the suppository inside you for at least 30 minutes
Note : Always use this medicine exactly as your doctor has told you. If you have any doubts or questions, consult your doctor.
Dulcoflex® in action
Hindi
Dulcoflex - Dheeru Veeru story - Breakfast
Hindi
Dulcoflex - Dheeru Veeru story - Phonecall
Hindi
Dulcoflex - Dheeru Veeru story - Cycling
Real Relief
Learn how reclaiming control over your digestive well-being looks like
Dulcoflex® has been a game-changer for me as a teacher! With an already hectic schedule, dealing with constipation became a constant challenge. But thanks to Dulcoflex® I can now focus on teaching students with peace of mind.
As a construction worker, my job demands long-hours on site. Working with constipation is difficult because of my demanding work. But with Dulcoflex®, this problem has been solved. It has provided me with relief from constipation and keeps me going strong.
My work includes long hours of sitting and stressful deadlines. This sedentary lifestyle has led to constipation and affected my productivity at work.
Dulcoflex® has been a true saviour with its gentle relief, allowing me to work better.
Frequently asked questions
What is Dulcoflex® 5mg suppository?
Dulcoflex® 5mg suppository is a laxative medication for kids used for constipation.
How do Dulcoflex® 5mg suppositories work in children
Dulcoflex® 5mg suppositories work by stimulating the bowel muscles, facilitating bowel movements, and helping the stool pass in children
Are Dulcoflex® 5mg suppositories safe and effective for children?
Dulcoflex® 5mg suppositories can be well tolerated and effective for children when used as directed and under the guidance of a healthcare professional.
What are the uses of the Dulcoflex® 5mg suppository?
Dulcoflex® 5mg suppository is primarily used to treat constipation. Additionally, it can be used in some medical procedures to cleanse the intestines and assist with the passage of stool.
How long does it usually take for Dulcoflex® 5mg suppositories to show effect in children?
Dulcoflex® 5mg suppositories typically stimulate a bowel movement within approximately 20 minutes after insertion in children.
For more information, visit www.sanofi.in
References:
1. IMS MAT April’23
2. Prescribing Information for Bisacodyl CCDS V1 dated 23rd Apr 2020 sanofi.in/dam/jcr:659be037-3aa9-4c23-bd9d-2791888f9539/Dulcoflex PI_Sep 2021.pdf Accessed on 23rd June 2023
3. National Center for Biotechnology Information. PubChem Compound Summary for CID 2391, Bisacodyl. https://pubchem.ncbi.nlm.nih.gov/compound/Bisacodyl.
4. Levine, Jules, and Seymour H. Rinzler. "Comparison of laxative action of bisacodyl suppositories and glycerin suppositories in acute myocardial infarction∗." The American journal of cardiology 5.1 (1960): 108-110.
5. Wald, A. Is chronic use of stimulant laxatives harmful to the colon? J.Cpn.Gastroenterol. 2003; 36(5):386-389.
6. Wald, A. Constipation in the primary care setting: current concepts and misconceptions. Am.J.Med. 2006; 119(9):736-739.
7. Muller-pssner, S. A. et. al. Myths and misconceptions about chronic constipation. Am.J.Gastroenterol. 2005; 100(1):232-242.
8. Nelson AD, Camilleri M, Chirapongsathorn S, Vijayvargiya P, Valentin N, Shin A, Erwin PJ, Wang Z, Murad MH. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis. Gut. 2017 Sep;66(9):1611-1622. doi: 10.1136/gutjnl-2016-311835. Epub 2016 Jun 10.
9. Kienzle-Horn, S. et. al. Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-bpnd, randomized, placebo-controlled study. Apment.Pharmacol.Ther. 2006; 23(10):1479-1488.
10. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin. 2007 Apr;23(4):691-9. doi: 10.1185/030079907x178865.
11. Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S; American Gastroenterological Association Institute Cpnical Guidepnes Committee. American Gastroenterological Association Institute Guidepne on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan;156(1):218-226. doi: 10.1053/j.gastro.2018.07.016.PMID30340754
12. Package Insert